Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.

Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.

Clin Neuropharmacol. 2011 Nov-Dec;34(6):234-40. doi: 10.1097/WNF.0b013e3182348abe.

PMID:
21996648
2.

Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.

Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.

Basic Clin Pharmacol Toxicol. 2012 Apr;110(4):370-7. doi: 10.1111/j.1742-7843.2011.00825.x. Epub 2011 Nov 18.

3.

Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.

Kumar S, Savitz S, Schlaug G, Caplan L, Selim M.

Neurology. 2006 Apr 25;66(8):1153-8; discussion 1135.

PMID:
16636230
4.

Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?

Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG.

Neurology. 2007 May 15;68(20):1687-93.

PMID:
17502550
5.

Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.

Koton S, Molshatzki N, Bornstein NM, Tanne D.

Cerebrovasc Dis. 2012;34(3):213-20. doi: 10.1159/000342302. Epub 2012 Sep 18.

PMID:
23006641
6.

Statin treatment withdrawal in ischemic stroke: a controlled randomized study.

Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J.

Neurology. 2007 Aug 28;69(9):904-10.

PMID:
17724294
7.

Prior antiplatelet use and infarct volume in ischemic stroke.

Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL.

J Neurol Sci. 2008 Jan 15;264(1-2):140-4. Epub 2007 Sep 12.

PMID:
17854835
8.

Effect of prior medical treatments on ischemic stroke severity and outcome.

Sacco S, Toni D, Bignamini AA, Zaninelli A, Gensini GF, Carolei A; SIRIO Study Group.

Funct Neurol. 2011 Jul-Sep;26(3):133-9.

9.

The effect of statin pretreatment on infarct volume in ischemic stroke.

Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ.

Neuroepidemiology. 2008;31(1):48-56. doi: 10.1159/000140095. Epub 2008 Jun 18.

PMID:
18560243
10.

Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study.

Aboa-Eboulé C, Binquet C, Jacquin A, Hervieu M, Bonithon-Kopp C, Durier J, Giroud M, Béjot Y.

J Neurol. 2013 Jan;260(1):30-7. doi: 10.1007/s00415-012-6580-9. Epub 2012 Jun 24.

PMID:
22729388
12.

Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.

Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.

Cerebrovasc Dis. 2010 Feb;29(3):263-7. doi: 10.1159/000275500. Epub 2010 Jan 15.

PMID:
20090317
13.

Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.

Galindo-Ocaña J, Bernabeu-Wittel M, Formiga F, Fuertes-Martín A, Barón-Franco B, Murcia-Zaragoza JM, Moreno-Gaviño L, Ollero-Baturone M; PROFUND Project researchers.

Eur J Intern Med. 2012 Mar;23(2):179-84. doi: 10.1016/j.ejim.2011.06.004. Epub 2011 Jul 13.

PMID:
22284251
14.

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.

Arch Neurol. 2008 May;65(5):607-11. doi: 10.1001/archneur.65.5.noc70077. Epub 2008 Mar 10.

PMID:
18332238
15.

Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.

Yu AY, Keezer MR, Zhu B, Wolfson C, Côté R.

Cerebrovasc Dis. 2009;27(4):398-402. doi: 10.1159/000207444. Epub 2009 Mar 10.

PMID:
19276623
16.

Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease.

Athyros VG, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, Elisaf M; GREACE Study Collaborative Group.

J Hum Hypertens. 2004 Nov;18(11):781-8.

PMID:
15229622
17.

Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.

Cappellari M, Deluca C, Tinazzi M, Tomelleri G, Carletti M, Fiaschi A, Bovi P, Moretto G.

J Neurol Sci. 2011 Sep 15;308(1-2):128-34. doi: 10.1016/j.jns.2011.05.026. Epub 2011 Jun 16.

PMID:
21683374
18.

Angiotensin 2 type 2 receptor activity and ischemic stroke severity.

Ovbiagele B, Kidwell CS, Starkman S, Selco SL, Rajajee V, Razinia T, Saver JL.

Neurology. 2005 Sep 27;65(6):851-4.

PMID:
16186522
19.

Statins in ischemic stroke: just low-density lipoprotein lowering or more?

Stead LG, Vaidyanathan L, Kumar G, Bellolio MF, Brown RD Jr, Suravaram S, Enduri S, Gilmore RM, Decker WW.

J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):124-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.09.016.

PMID:
19251188
20.

Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, Luijckx GJ, De Keyser J.

J Neurol. 2008 Jun;255(6):875-80. doi: 10.1007/s00415-008-0797-7. Epub 2008 Mar 14.

PMID:
18338194

Supplemental Content

Support Center